Cascade‐Amplifying Immunophototherapy Nanoplatform Integrating Cocktail Drug Delivery
Small · 2026
DOI: 10.1002/smll.75166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von E Pang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Central South University, Changsha, People's Republic of China. Hauptthemen laut MEDLINE: Drug Delivery Systems, Photochemotherapy, Nanoparticles, Immunotherapy. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, The Fundamental Research Funds for the Central Universities of Central South University.
Abstract (Originalsprache)
Photodynamic therapy (PDT) offers the advantages of non‐invasiveness, non‐drug resistance, and high selectivity. However, its efficacy against melanoma is substantially limited by tumor hypoxia, elevated glutathione levels, and the strong antioxidant and light‐absorbing properties of melanin. Herein, we developed a cascade‐amplified biomimetic nanoplatform (Cyan‐Cu) by assembling cyanobacteria (Cyan) and DSPE‐PEG‐NH 2 ‐decorated copper (II) phthalocyanine (CuPc) for enhanced melanoma therapy. Under 635 nm laser irradiation, the Cyan‐Cu not only simultaneously generates both reactive oxygen species and heat for immunophototherapy, but also functions as a cocktail drug delivery system. In contrast to conventional microalgae used merely as photosynthetic oxygen generator or delivery vector, the Cyan effectively suppresses tyrosinase activity, thereby limiting the synthesis of antioxidant melanin and significantly potentiating both PDT and cuproptosis. Notably, the photothermal effect cascades to trigger Cyan disintegration into small cytotoxic fragments, enabling deeper tumor penetration for amplified anti‐tumor efficacy. In vivo studies demonstrated that the Cyan‐Cu platform reduced intratumoral melanin content while suppressing bilateral tumor growth via dual‐mode immune activation. This work underscores the pivotal role of Cyan in antimelanoma therapy and illustrates the therapeutic potential of the Cyan‐Cu platform as a multimodal synergistic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, Central South University, Changsha, People's Republic of China.
- Department of Breast and Thyroid Gland Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
- School of Mechanical and Electrical Engineering, Central South University, Changsha, People's Republic of China.
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials and CityU-CAS Joint Laboratory of Functional Materials and Devices, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beij…
ORCID-Profile: E Pang, Jianing Yi, Xiuli Zheng, Xiangzhi Song, Pengfei Wang, Minhuan Lan
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- The Fundamental Research Funds for the Central Universities of Central South University
- Postgraduate Innovative Project of Central South University
Zitieren
APA
Pang, E., Tang, Y., Zhao, S., Yi, J., Yu, X., Zheng, X., Chen, Z., Song, X., Wang, P., & Lan, M. (2026). Cascade‐Amplifying Immunophototherapy Nanoplatform Integrating Cocktail Drug Delivery. Small. https://doi.org/10.1002/smll.75166
Vancouver
Pang E, Tang Y, Zhao S, Yi J, Yu X, Zheng X, et al. Cascade‐Amplifying Immunophototherapy Nanoplatform Integrating Cocktail Drug Delivery. Small. 2026. doi:10.1002/smll.75166
BibTeX
@article{Pang2026,
author = {Pang, E and Tang, Yuanyu and Zhao, Shaojing and Yi, Jianing and Yu, Xize and Zheng, Xiuli and Chen, Zeyu and Song, Xiangzhi and Wang, Pengfei and Lan, Minhuan},
title = {Cascade‐Amplifying Immunophototherapy Nanoplatform Integrating Cocktail Drug Delivery},
journal = {Small},
year = {2026},
doi = {10.1002/smll.75166}
}
EUVIMED